These results suggest that the inhibitor CHX could not completely block protein synthesis stimulated by Lexa in HCC cells and that apoptosis induced by combination treatment of Lexa and CHX may be mediated by Bax/Bak activation. The gene discussed is BAK1; the disease is hepatocellular carcinoma.